Myelodysplastic Syndrome from FAB Classification to thePresent Time. New Sub-units or Independent Groups?
Authors:
A. Jonášová; R. Neuwirtová
Authors‘ workplace:
I. interní klinika VFN 1. LF UK, Praha, Dana Farer Cancer Institute, Harvard Medical School, Boston, USA
Published in:
Transfuze Hematol. dnes,, 2003, No. 1, p. 5-12.
Category:
Overview
The authors present a review of some sub-units of MDS with a specific clinical and laboratory characteristic.The myelodysplastic syndrome (MDS) must be divided into sub-types either according to FABor WHO classification. When establishing the diagnosis it is important to state whether primary orsecondary MDS is involved. Nowadays we can however define the diagnosis of MDS more accuratelyby assessing further sub-units which have their clinicalpicture,prognosisandlaboratory finding.Thesesub-units are divided into three groups: 1. mixed syndromes which comprise hypoplastic MDS andmixed MDS-MPS, 2. cases with a specific histological or morphological picture, i.e. MDS with myelofibrosis,MDSwith eosinophilia,MDS with aggregation of granulocyte chromatin, two forms of sideroblasticanaemia where we can add also idiopathic macrocytosis and finally 3. cases with specificcytogenetic findings such as the 5q minus, syndrome monosomy 7 in children, pathology of chromosome17 (17p-, isol17q) and some less frequent chromosomal aberrations. Knowledge of these sub-units willhelp us to establish the prognosis of the disease and thus also therapy decision.
Key words:
MDS diferentiation, overlap syndromes, morphological aberrations, fibrousis, cytogeneticsub-units
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2003 Issue 1
Most read in this issue
- Weak and Variant RhD Antigens – Characteristics andFrequency of Types Investigated in 1997–2002 in the Reference Laboratory for Immunohaematology
- Stem Cell Transplantation in Children with Myelodysplastic Syndromein the Czech Republic 1997–2002
- The Incidence,Diagnosis and Treatment of Myelodysplastic Syndrome in Children in the Czech Republic:Results of the Prospective Study of the EWOG-MDS 1998–2002
- Changes of the Mean Platelet Volume during Body WeightReduction